A multi-center cross-sectional study to explore cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy - Top-Institutions - MDSpire

A multi-center cross-sectional study to explore cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy

  • By

  • Dominik Morlok

  • Laura Bieniosek

  • Hansjörg Baurecht

  • Melanie Reitz

  • Thomas Okon

  • Janina Meuer

  • Christine Welker

  • Wolfgang Herr

  • Tobias Pukrop

  • Sabine Einhell

  • Anika Berling-Ernst

  • Annalena Wehner

  • Mirko Brandes

  • Sebastian Theurich

  • Bernardine Madl

  • Louisa Sell

  • Thorsten Schmidt

  • Patrick Jahn

  • Carlotta Evers

  • Rebecca Zimmer

  • Renee Stark

  • Hajo Zeeb

  • Michael Leitzmann

  • Freerk T. Baumann

  • Anne Herrmann

  • June 10, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    University of Bremen
    University of Bremen

    Bremen, Germany

    Key Differentiators

    • Oncology

  • #3

    Bavarian Cancer Research Center
    Bavarian Cancer Research Center

    Bavaria, Germany

    Key Differentiators

    • Oncology

  • #4

    Penn State Cancer Institute
    Penn State Cancer Institute

    Hershey, PA

    Key Differentiators

    • Oncology

  • #5

    American College of Sports Medicine
    American College of Sports Medicine

    Indianapolis, IN

    Key Differentiators

    • Oncology

Original Source(s)

A multi-center cross-sectional study to explore cancer patients’ views on facilitators and barriers for the implementation of oncological exercise therapy

  • by Dominik Morlok, Laura Bieniosek, Hansjörg Baurecht, Melanie Reitz, Thomas Okon, Janina Meuer, Christine Welker, Wolfgang Herr, Tobias Pukrop, Sabine Einhell, Anika Berling-Ernst, Annalena Wehner, Mirko Brandes, Sebastian Theurich, Bernardine Madl, Louisa Sell, Thorsten Schmidt, Patrick Jahn, Carlotta Evers, Rebecca Zimmer, Renee Stark, Hajo Zeeb, Michael Leitzmann, Freerk T. Baumann, Anne Herrmann

  • June 10, 2026

Related Content

AAT score based on pretreatment indicators predicts outcomes in unresectable HCC patients treated with TACE, Sintilimab, and Bevacizumab

Long-read sequencing for cancer liquid biopsy: advancing precision oncology

Cross-platform evaluation of LLM-generated educational texts on cardiac myxoma: quality, readability, and actionability using network analysis and latent profile analysis